擅长

从事专业二十年，擅长肺脏、食管、纵膈、胸腺外科的常见病、疑难病如肺癌、食管癌、支气管扩张、重症肌无力、漏斗胸等的外科治疗和微创治疗，胸部肿瘤的化疗和靶向治疗。

简介

陈振光，医学博士，中山一院胸外科主任医师、硕士生导师，中山一院东院院长助理、心胸外科主任，兼任欧洲临床肿瘤学会(ESMO)会员，中国医师协会胸外科分会委员，广东省医院协会第九届理事，广东省医院协会肿瘤防治管理分会秘书长及胸部肿瘤专业委员会副主任委员，广东省医学会细胞治疗学分会常委，广东省医学会胸外科学会委员，广东省医师协会胸外科分会委员，广东省医疗行业协会胸外科分会常委，广州东部医学论坛秘书长及呼吸专业委员会副主任委员，广州市医学会中青年学术研究会常委，国家自然科学基金评审专家，广东省自然科学基金评审专家，《中国组织工程与临床康复杂志》执行编委，Medicine（IF5.7）、BMCCancer(IF3.3)、PLOSOn（IF3.2）、ThoracCancer（IF1.1）、JCardiothoracSurg（IF1.0）、ClinicalMedicalInsights:Oncology、CellProliferation、JSolidTumor、ChineseMedJ-Peking（IF1.601）等杂志审稿专家。主要研究方向为肺癌的分子发病机制和治疗以及重症肌无力的外科治疗。曾在2ndEuropeanLungCancerConference(ELCC,Geneva)大会发言，并获得TravelAwardof2ndEuropeanLungCancerConference(ELCC,Geneva)和TravelAwardof35thEuropeanSocietyforMedicalOncology(ESMO，Milan），已发表论文近60篇，并在AnnOncol(IF7.0)、Oncotarget(IF6.4)、Medicine(IF5.7)、AnnThoracSurg(IF3.8)、EurJCardiothoracSurg(IF3.3)、PLoSOne(IF3.2)、JThoracOncol(IF5.3)、HumPathol(IF2.8)、JExpClinCancerRes(IF4.4)、CancerCellInternational(IF2.8)、MedOncol(IF2.6)、JCardiothoracSurg(IF1.0)、JIntMedRes(IF1.4)等SCI杂志发表论文近30篇，总影响因子74.5。已发表论文：1.RelationshipofOct-4tomalignantstage:ameta-analysisbasedon502positive/highOct-4casesand522negative/lowcase-freecontrols.ZhongB,LinY,LaiY,ZhenngX,HuangR,YangW,ChenZ(通讯作者).Oncotarget.2015Nov9.doi:10.18632/oncotarget.5737.[Epubaheadofprint]IF6.42.ChenZ(通讯作者),ZhongB,LunX,LaiY,BellaAE,YangW,WuJ.SpecificSafetyProfileofBevacizumabinAsianPatientsWithAdvancedNSCLC:AMeta-Analysis.Medicine(Baltimore).2015Jun;94(24):e975.IF5.73.Associationoftheintermediatefilamentnestinwithcancerstage:ameta-analysisbasedon223positive/highnestincasesand460negative/lowcase-freecontrols.ZhongB,WangT,ZouJ,ZhengF,HuangR,ZhengX,YangW,ChenZ(通讯作者).Oncotarget.2015May8,Vol6,No26:22970-22977.IF6.44.WangT,YangW,LiW,XiangAP,ChenZ(通讯作者).Contributionofmesenchymalstemcells(MSCs)onepithelial-mesenchymaltransition(EMT)ofesophagealsquamouscellcarcinoma.PosterpresentationatEuropeanSocietyforMedicalOncology(ESMO)2014Congress,Madrid,Spain(No.157P).5.ChenZ(通讯作者),ZhongB,WangT,YangW,LiW,XiangAP.Nestinpromotesproliferationandapoptosisandcorrelateswithpoorprognosisinesophagealsquamouscellcarcinoma.PosterpresentationatEuropeanSocietyforMedicalOncology(ESMO)2014Congress,Madrid,Spain(No.219P).6.YangW,ChenZ(通讯作者),WangT,LiW,XiangAP.Clinicalpathologicalcharacteristicsofcancer-associated-fibroblastinesophagealsquamouscellcarcinoma.PosterpresentationatEuropeanSocietyforMedicalOncology(ESMO)2014Congress,Madrid,Spain(No.1594P).7.ChenZ(通讯作者)，WangTao,etal.Stemcellmarkernestinexpressioncorrelateswithproliferationandcellcycleinnon-smallcelllungcancer.Posterpresentationat35thEuropeanSocietyforMedicalOncology(ESMO)Congress,Milan,2010,Italy(No.1594P).TravelAwardofEuropeanSocietyforMedicalOncology(ESMO,Milan,2010）.8.ChenZ(通讯作者),WangT,LuoH,YangX,HaoY,SuC,LeiY,LiF,PanH,ZhangX,LahnBT,XiangAP.Nestinexpressioninnon-smallcelllungcanceranditsrelevancewithprognosticsignificance.Oralpresentationat2ndEuropeanLungCancerConference(ELCC,Geneva,2010,No.910).TravelAwardof2ndEuropeanLungCancerConference(ELCC,Geneva,2010)10.BeilongZhong,ChenZhenguang(通讯作者),etal.Contributionofnestinpositiveesophagealsquamouscancercellsonmalignantproliferation,apoptosis,andpoorprognosis.CancerCellInternational2014,14:57.IF2.811.ChenZhenguang(通讯作者)，WangJianjun,etal.Roleofthestemcell-associatedintermediatefilamentnestininmalignantproliferationofnon-smallcelllungcancer.PLoSOne2014Feb3;9(2):e85584.doi:10.1371/journal.pone.0085584.eCollection2014.IF3.212.ChenZhenguang(通讯作者)，ZuoJidong,etal.Cellularimmunityfollowingvideo-assistedthoracoscopicandopenresectionfornon-thymomatousmyastheniagravis.EurJCardiothoracSurg2014,Apr,45(4):646-651.IF3.313.LiuZhaoguo,LeiYiyan,ChenZhenguang(通讯作者),etal.Theco-expressionofERβ2andIL-12Rβ2isbetterprognosticfactorinnon-small-celllungcancerprogression.MedOncol2013;30(3):592.doi:10.1007/s12032-013-0592-x.IF2.614.ChenZhenguang(通讯作者)，WangTao,etal.Nestinexpressioninnon-smallcelllungcanceranditsrelevancewithprognosticsignificance.JThoracOncol2010,5(Suppl1):S39.IF5.315.ChenZhenguang(通讯作者)，WangTao,etal.Stemcellmarkernestinexpressioncorrelateswithproliferationandcellcycleinnon-smallcelllungcancer.AnnOncol2010,21(Suppl8):viii130.IF7.016.ChenZhenguang(通讯作者)，WangTao,LuoHonghe,etal.Expressionofnestinregardingtolymphnodemetastasisandlymphangiogenesisinnon-smallcelllungcancerpatients.HumPathol2010,41:737-744.IF2.817.ChenZhenguang(通讯作者)，PanHongxin,WangTao,etal.Primarythymicseminomaina32-year-oldfemale.AnnOncol2010,May;21(5):1132-4.IF7.018.ChenZhenguang(通讯作者)，WangTao,CaiLie,etal.Clinicopathologicalsignificanceofnon-smallcelllungcancerwithhighprevalenceofOct-4tumorcells.JExpClinCancerRes2012,31:10.IF4.417.ChenZhenguang(通讯作者),LuoHonghe,PengYanwen,etal.Comparativeclinicalfeaturesandimmuneresponsesafterextendedthymectomyformyastheniagravisinpatientswithatrophicversushyperplasticthymus.AnnThoracSurg2011,Jan;91(1):212-218.IF3.818.SuChunhua,Luohonghe,ChenZhenguang(通讯作者),etal.DifferentpatternsofNF-κBandNotch1signalingcontributetotumor-inducedlymphangiogenesisofesophagealsquamouscellcarcinoma.JExpClinCancerRes2011,30:85.IF4.419.LuoHonghe,ChenZhenguang(通讯作者),JinHui,etal.Cyclooxygenase-2up-regulatesvascularendothelialgrowthfactorviaaproteinkinaseCpathwayinnon-smallcelllungcancer.JExpClinCancerRes2011,Jan10;30(1):6.IF4.420.ChenZhenguang(通讯作者),LuoHonghe,ZhuangMei,etal.Effectsofischemicpreconditioningonischemia/reperfusion-inducedarrhythmiasbyupregulatationofconnexin43expression.JCardiothoracSurg2011;6:80.IF1.021.ChenZhenguang(通讯作者),AmosElaBella,LuoHonghe,etal.ComparativepulmonaryfunctionalrecoveryafterNussandRavitchproceduresforpectusexcavatumrepair:ameta-analysis.JCardiothoracSurg2012;7:101.IF1.022.SuChunhua,SuYihua,ChenZhenguang(通讯作者),etal.Intravenousflurbiprofenforpost-thymectomypainreliefinpatientswithmyastheniagravis.JCardiothoracSurg2012;7:98.IF1.023.LuoHonghe,LeiYiyan,ChenZhenguang(通讯作者),etal.Primarycardiacosteosarcomaina42-year-oldwoman.JCardiothoracSurg2010,27;5:120.IF1.024.Clinicaloutcomeandpredictivefactorsofirradiation-associatedmyastheniagravisexacerbationinthymomatouspatients.LiY,ChenP,DingL,LuoC,WangH,ChenZ,SuC,FengH,HuangX,XiaW,LiuW.NeurolSci.2015Nov;36(11):2121-7.doi:10.1007/s10072-015-2325-8.Epub2015Jul26.25.ZouJianyong,AmosElaBella,ChenZhenguang,etal.FrequencyofEGFRmutationsinlungadenocarcinomawithmalignantpleuraleffusion:ImplicationofcancerbiologicalbehaviourregulatedbyEGFRmutation.JIntMedRes2014Oct;42(5):1110-7.doi:10.1177/0300060514539273.IF1.426.同种移植大鼠心脏II类主要组织相容性抗原表达及其机制探讨。中华心血管病杂志，2003，Vol31,No2。27.移植心Th细胞免疫偏离与MHCII类抗原表达的关系。中国病理生理杂志，2002，6，18（6）。28.小体重大鼠供心移植模型的建立和MHCII类抗原的分布。中华实验外科杂志，2001，12，18（增刊）29.严重闭合性胸外伤30例的并发症诊治体会。新医学，2001，32（5）。30.血管通路比例对大鼠颈部心脏移植模型的影响。中山医科大学学报，2001，22(2)。31.大鼠移植心心电图改变与急性排斥相关关系。中山医科大学学报，2001，22(4)。32.心脏移植急性免疫排斥反应的研究进展。新医学，2001，6，32。33.心脏直视手术中的心肌保护。新医学，2005，7，36（7）。...